Sol-Gel Technologies Ltd. (SLGL)

0.8569 -0.0877 (-9.28%) At close: 04:00PM EDT

Sol-Gel Technologies Ltd.

7 Golda Meir Street
Weizmann Science Park
Ness Ziona 7403650
Israel
972 8 931 3433
https://www.sol-gel.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 36

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Alon Seri-Levy	Co-Founder, CEO & Director	411k	N/A	1961
Mr. Gilad Mamlok	Chief Financial Officer	367k	N/A	1968
Dr. Itzik Yosef	Chief Operating Officer	236k	N/A	1976
Mr. Moshe Arkin	Executive Chairman of the Board	N/A	N/A	1953
Prof. David Avnir	Co-Founder	N/A	N/A	N/A
Ms. Tamar Fishman Jutkowitz	VP & General Counsel	N/A	N/A	1976
Dr. Karine Neimann	VP of Projects & Planning and Chief Chemist	N/A	N/A	1971

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Corporate governance

Sol-Gel Technologies Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.